Predictors of early and late mortality after the treatment for early gastric cancers
- PMID: 34662456
- DOI: 10.1111/den.14172
Predictors of early and late mortality after the treatment for early gastric cancers
Abstract
Objectives: Although many patients with early gastric cancers (EGCs) die of non-gastric cancer-related causes, the association of the risk categories of lymph node metastasis (LNM) with all-cause mortality remains unclear. We aimed to clarify the predictors of early and late mortality, separately.
Methods: Patients with endoscopic resection or gastrectomy for EGCs between 2003 and 2017 were retrospectively enrolled. We analyzed predictors for early and late mortality, including risk categories of LNM, treatment method, and nine non-cancer-related indices, separately, with a cut-off value of 3 years.
Results: We enrolled 1439 patients with a median follow-up period of 79 months. The 5-year overall survival rate was 86.8%. In the multivariate Cox analysis, the most important predictors for early and late mortality were age ≥85 years (hazard ratio [HR] 2.88 and 4.54, respectively) and Eastern Cooperative Oncology Group Performance Status ≥2 (HR 3.00 and 4.19, respectively). Charlson comorbidity index ≥2 (HR 2.76 and 1.99, respectively), American Society of Anesthesiologists Physical Status ≥3 (HR 2.35 and 1.79, respectively), and C-reactive protein/albumin ratio ≥0.028 (HR 2.30 and 1.58, respectively) were also predictors for both early and late mortality. Male (HR 2.26), intermediate- (HR 2.12)/high-risk (HR 1.85) of LNM in eCura system, and sarcopenia evaluated by the psoas muscle mass index (HR 1.70) were predictors for early mortality.
Conclusion: The combined assessment of multiple predictors might help to predict early and/or late mortality in patients with EGCs. The eCura system was associated with early mortality.
Keywords: gastric cancer; nutrition assessment; prognosis; sarcopenia.
© 2021 Japan Gastroenterological Endoscopy Society.
Comment in
-
It is time to tailor endoscopic resection for early gastric cancer: Evaluate not only lesion but also patient.Dig Endosc. 2022 May;34(4):826-827. doi: 10.1111/den.14271. Epub 2022 Mar 29. Dig Endosc. 2022. PMID: 35352401 No abstract available.
References
-
- Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 2021; 24: 1-21.
-
- Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-54.
-
- Hatta W, Gotoda T, Oyama T et al. Is additional surgery always sufficient for preventing recurrence after endoscopic submucosal dissection with curability C-2 for early gastric cancer? Ann Surg Oncol 2019; 26: 3636-43.
-
- Hatta W, Gotoda T, Oyama T et al. Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study. Gastric Cancer 2018; 21: 481-9.
-
- Hatta W, Gotoda T, Oyama T et al. Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan. J Gastroenterol 2017; 52: 175-84.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
